menu
    • menu

    Company profile for PharmAbcine

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    PharmAbcine Inc. is a bio venture specialized in R&D of antibody treatment in the clinical stage and currently possesses core technologies such as potent antibody development technology using potent non-immune scFv phage display library, new-generation double target antibody production technology, and antibody production technology using cancer stem cell library. Since we were established in 2008 we have been devoted to dev...
    PharmAbcine Inc. is a bio venture specialized in R&D of antibody treatment in the clinical stage and currently possesses core technologies such as potent antibody development technology using potent non-immune scFv phage display library, new-generation double target antibody production technology, and antibody production technology using cancer stem cell library. Since we were established in 2008 we have been devoted to developing new cancer antibody drugs and laying a foundation for TTAC-0001 and PMC-001. We will constantly develop pipelines for sustainable growth with a vision to release a new global blockbuster bio drug by 2020.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    PharmAbcinekorearepublicofnew Flag
    Country
    Country
    South Korea
    Address
    Address
    2F, Research Building 2, 70, Yuseong-daero 1689 beon-gil, Yuseong-gu, Daejeon,...
    Telephone
    Telephone
    +82-42-863-2017
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.pharmabcine.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    PharmAbcine Announces Safety Approval For PMC-403 Trial
    PharmAbcine Announces Safety Approval For PMC-403 Trial

    14 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/pharmabcine-announces-safety-approval-for-4mg-single-dose-cohort-in-phase-1-clinical-trial-of-pmc-403-for-neovascular-age-related-macular-degeneration-302275767.html

    PR NEWSWIRE
    14 Oct 2024
    Share Share
    PharmAbcine's PMC-403 Trial For Macular Degeneration Advances
    PharmAbcine's PMC-403 Trial For Macular Degeneration Advances

    02 Jul 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/pharmabcines-phase-1-clinical-trial-of-pmc-403-for-neovascular-age-related-macular-degeneration-advances-to-both-single-dose-of-4mg-and-multiple-dose-of-3mg-302187664.html

    PR NEWSWIRE
    02 Jul 2024
    Share Share
    PharmAbcine's Wincal Presenting Ocular Data At ARVO 2024
    PharmAbcine's Wincal Presenting Ocular Data At ARVO 2024

    22 Apr 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/pharmabcines-us-subsidiary-wincal-biopharm-to-present-preclinical-data-from-its-proprietary-opc-platform-targeting-ocular-diseases-at-the-upcoming-association-for-research-in-vision-and-ophthalmology-arvo-annual-meeting-202-302123843.html

    PR NEWSWIRE
    22 Apr 2024
    Share Share
    PharmAbcine Publishes Study in Advances Demonstrating the Potential of PMC-403
    PharmAbcine Publishes Study in Advances Demonstrating the Potential of PMC-403

    22 Nov 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/pharmabcine-publishes-study-in-science-advances-demonstrating-the-potential-of-pmc-403-in-preclinical-models-of-idiopathic-systemic-capillary-leak-syndrome-301996385.html

    PR NEWSWIRE
    22 Nov 2023
    Share Share
    PharmAbcine Receives Approval to Advance to Dose Level 2 of Trial of PMC-403
    PharmAbcine Receives Approval to Advance to Dose Level 2 of Trial of PMC-403

    09 Nov 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/pharmabcine-receives-safety-review-committee-approval-to-advance-to-dose-level-2-of-clinical-trial-of-pmc-403-with-neovascular-age-related-macular-degeneration-following-dose-level-1-safety-data-301982534.html

    PR NEWSWIRE
    09 Nov 2023
    Share Share
    PharmAbcine Receives IND Approval from Korean MFDS forTIE2 Agonistic Antibody
    PharmAbcine Receives IND Approval from Korean MFDS forTIE2 Agonistic Antibody

    23 May 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/pharmabcine-receives-ind-approval-from-the-korean-mfds-for-phase-i-clinical-trial-of-its-novel-tie2-agonistic-antibody-in-namd-301831855.html

    PR NEWSWIRE
    23 May 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search